| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee1f2823cfb50f8cebb69de7f074d4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639cde93ad25c4794ecf02278c933fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23aad7312fbc4d1471065cf0f2a24ad3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e05471fae48ae3cde187d4a5e83d235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_357e803e527794ad9c11aa0f49745c76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb5e5d3b8362a2ca25e38deb6ed1f18b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c67d651d87e6a466196a2370b87a5c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3abb6a61e086ab19a5a5c1abdc7ece9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d7f04496df8bfcf0d41eee46038fba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4875761c652ea5c5d293eef209a6188c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdbb10ee58446f76070f7dd0490f461
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad418845a6e1731effe8bdb5d4ec6f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ccb8be0e0e5366f075d61b9b021db45 |
| publicationDate |
2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2920209-A1 |
| titleOfInvention |
Agents for treatment of claudin expressing cancer diseases |
| abstract |
The present invention provides binding agents that contain a binding domain that is specific for CD3 allowing binding to T cells and a binding domain that is specific for a tumor- associated claudin molecule and methods of using these binding agents or nucleic acids encoding therefor for treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023285560-A1 |
| priorityDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |